ECSP034468A - Compuesto farmaceutico novedoso - Google Patents

Compuesto farmaceutico novedoso

Info

Publication number
ECSP034468A
ECSP034468A EC2003004468A ECSP034468A ECSP034468A EC SP034468 A ECSP034468 A EC SP034468A EC 2003004468 A EC2003004468 A EC 2003004468A EC SP034468 A ECSP034468 A EC SP034468A EC SP034468 A ECSP034468 A EC SP034468A
Authority
EC
Ecuador
Prior art keywords
compound
pharmaceutical compound
new pharmaceutical
novel
thiazolidin
Prior art date
Application number
EC2003004468A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ECSP034468A publication Critical patent/ECSP034468A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Un novedoso compuesto farmacéutico novedoso, Meso-Tartrato de 5-(4-(2-N-metil-N-(2-piridil)amino)etoxi)bencil)tiazolidin-2,4-diona o un solvato del mismo, un procedimiento para preparar dicho compuesto, una composición farmacéutica que comprende dicho compuesto y el uso de dicho compuesto en medicina.
EC2003004468A 2000-08-04 2003-02-04 Compuesto farmaceutico novedoso ECSP034468A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ECSP034468A true ECSP034468A (es) 2003-03-31

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004468A ECSP034468A (es) 2000-08-04 2003-02-04 Compuesto farmaceutico novedoso

Country Status (23)

Country Link
EP (1) EP1307448A1 (es)
JP (1) JP2004505971A (es)
KR (1) KR20030022356A (es)
CN (1) CN1458930A (es)
AP (1) AP2003002737A0 (es)
AU (1) AU2001276508A1 (es)
BG (1) BG107605A (es)
BR (1) BR0112984A (es)
CA (1) CA2417828A1 (es)
CZ (1) CZ2003314A3 (es)
EA (1) EA200300231A1 (es)
EC (1) ECSP034468A (es)
GB (1) GB0019226D0 (es)
HU (1) HUP0300770A2 (es)
IL (1) IL154277A0 (es)
MA (1) MA25830A1 (es)
MX (1) MXPA03001086A (es)
NO (1) NO20030508L (es)
OA (1) OA12355A (es)
PL (1) PL360702A1 (es)
SK (1) SK1452003A3 (es)
WO (1) WO2002012233A1 (es)
ZA (1) ZA200300962B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
NO20030508D0 (no) 2003-01-31
IL154277A0 (en) 2003-09-17
NO20030508L (no) 2003-03-20
BG107605A (bg) 2003-09-30
MXPA03001086A (es) 2003-05-27
CN1458930A (zh) 2003-11-26
EP1307448A1 (en) 2003-05-07
WO2002012233A1 (en) 2002-02-14
GB0019226D0 (en) 2000-09-27
EA200300231A1 (ru) 2003-06-26
KR20030022356A (ko) 2003-03-15
JP2004505971A (ja) 2004-02-26
ZA200300962B (en) 2003-10-29
CZ2003314A3 (cs) 2004-02-18
BR0112984A (pt) 2003-06-10
OA12355A (en) 2004-03-19
CA2417828A1 (en) 2002-02-14
MA25830A1 (fr) 2003-07-01
SK1452003A3 (en) 2004-05-04
PL360702A1 (en) 2004-09-20
HUP0300770A2 (hu) 2003-11-28
AU2001276508A1 (en) 2002-02-18
AP2003002737A0 (en) 2003-03-31

Similar Documents

Publication Publication Date Title
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
UY25304A1 (es) Forma hidratada de maleato de rosiglitazona
AR015894A1 (es) Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona e insulina para la preparacion de un medicamento y composicion farmaceuticaque contiene dichos compuestos
ECSP034469A (es) Compuesto farmaceutico novedoso
ECSP034467A (es) Farmaceutico novedoso
ECSP034466A (es) Farmaceutico novedoso
ECSP034505A (es) La sal de clorhidrato de 5-[4-(2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2, 4-diona
AR023563A1 (es) Monohidrato de hidrocloruro de un derivado de tiazolidin-2,4-diona, una composicion farmaceutica y el uso del mismo para la fabricacion de un medicamento
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
GB0021784D0 (en) Novel pharmaceutical
ECSP034529A (es) Derivado de tiazolidinodiona y su uso como antidiabetico
ECSP034528A (es) Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
EA200300004A1 (ru) Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата
BR0112984A (pt) Sais tartarato de derivado de tiazolidinodiona
BR0111536A (pt) Sal de tiazolidinediona para tratamento de diabetes mellitus
ECSP034463A (es) Composicion farmaceutica
ECSP003434A (es) Nuevos compuestos
ECSP003435A (es) Nuevos compuestos
SI1448559T1 (sl) 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil-tiazolidin-2,4-dion- benzensulfonat; postopek za njegovo pripravo; njegovi polimorfi i, ii, iii; in njegova uporaba kot farmacevtska uäśinkovina
AR018994A1 (es) Compuestos tiazolidindiona, un proceso para su preparacion, composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento